Barinthus Biotherapeutics (BRNS) EBIT Growth (3y) (2023 - 2026)
Barinthus Biotherapeutics (BRNS) EBIT Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -1,580.97% |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 32.96% |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -29.67% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -50.81% |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 16.35% |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 13.47% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - | 34.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.36% |
| Dec 31, 2025 | 22.76% |
| Sep 30, 2025 | -59.82% |
| Jun 30, 2025 | -55.53% |
| Mar 31, 2025 | -222.36% |
| Dec 31, 2024 | -11.96% |
| Sep 30, 2024 | -19.22% |
| Jun 30, 2024 | -2.77% |
| Mar 31, 2024 | -39.94% |
| Dec 31, 2023 | -27.55% |
| Sep 30, 2023 | -124.26% |
| Jun 30, 2023 | -82.46% |
| Mar 31, 2023 | -66.57% |